- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Pharmaceutical Quality Management Software Market To Reach $2.98 Billion By 2030
Rapid growth driven by focus on compliance, efficiency, and data-driven decision-making
Mar. 30, 2026 at 6:23pm
Got story updates? Submit your updates here. ›
A refined, data-driven approach to quality management is driving growth in the pharmaceutical software market.Delray Beach TodayThe global Pharmaceutical Quality Management Software (QMS) Market is projected to grow from $1.59 billion in 2025 to $2.98 billion by 2030, registering a CAGR of 13.3%. This growth is driven by increasing emphasis on end-to-end product lifecycle management, automation of critical workflows, and advanced analytics enabling data-driven decision-making.
Why it matters
Maintaining stringent quality standards across drug development, manufacturing, and distribution is critical in the highly regulated pharmaceutical industry. Robust QMS solutions help pharmaceutical companies ensure product consistency, improve traceability, minimize compliance risks, and support continuous improvement initiatives.
The details
The pharmaceutical quality management software market is advancing rapidly due to increasing emphasis on end-to-end product lifecycle management. Automation of critical workflows such as CAPA, audits, and change management is reducing human error and improving efficiency, while advanced analytics are enabling data-driven decision-making. Stricter regulatory scrutiny, particularly in emerging markets, along with the shift toward paperless operations and a strong focus on patient safety, are also reinforcing the adoption of QMS platforms.
- The global Pharmaceutical Quality Management Software (QMS) Market is projected to grow from $1.59 billion in 2025 to $2.98 billion by 2030.
- The market is expected to register a CAGR of 13.3% during the forecast period.
The players
MarketsandMarkets™
A leading market research firm that has provided the insights and data for this report.
Veeva Systems Inc.
One of the key players operating in the pharmaceutical quality management software market.
MasterControl Solutions, Inc.
One of the key players operating in the pharmaceutical quality management software market.
What’s next
As regulatory complexity increases and digital transformation accelerates, pharmaceutical quality management software will play a central role in enabling organizations to deliver safe, effective, and compliant products to market. Decision-makers should prioritize investing in integrated, scalable, and cloud-enabled quality management systems to ensure compliance, improve operational efficiency, and maintain product quality across global operations.
The takeaway
The rapid growth of the pharmaceutical quality management software market highlights the industry's increasing focus on compliance, efficiency, and data-driven decision-making. Pharmaceutical companies are leveraging advanced QMS solutions to streamline operations, minimize risks, and ensure the delivery of safe and effective products to patients.
